Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines.
We are experts in live virus vaccine manufacturing with our own end-to-end commercial-scale manufacturing facilities and a network of partners worldwide to expand capacity and supply as needed.
We have a strong heritage in vaccine development and with a proven technology, we continue to make innovations to help fight existing and emerging diseases.
With more than 30 years of vaccine excellence, we employ nearly 1,400 people specialized in research and development, manufacturing and commercialization of vaccines.
We are headquartered in Denmark and have facilities in the USA, Germany and Switzerland.
We have established a commercial infrastructure with presence in key markets in Europe and the USA to serve our customers with an expanding portfolio of vaccines.
For more information, visit www.bavarian-nordic.com.